TY - JOUR
T1 - Recommendations for asthma monitoring in children
T2 - A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO
AU - Papadopoulos, Nikolaos G.
AU - Custovic, Adnan
AU - Deschildre, Antoine
AU - Gern, James E.
AU - Nieto Garcia, Antonio
AU - Miligkos, Michael
AU - Phipatanakul, Wanda
AU - Wong, Gary
AU - Xepapadaki, Paraskevi
AU - Agache, Ioana
AU - Arasi, Stefania
AU - Awad El-Sayed, Zeinab
AU - Bacharier, Leonard B.
AU - Bonini, Matteo
AU - Braido, Fulvio
AU - Caimmi, Davide
AU - Castro-Rodriguez, Jose A.
AU - Chen, Zhimin
AU - Clausen, Michael
AU - Craig, Timothy
AU - Diamant, Zuzana
AU - Ducharme, Francine M.
AU - Ebisawa, Motohiro
AU - Eigenmann, Philippe
AU - Feleszko, Wojciech
AU - Fierro, Vincezo
AU - Fiocchi, Alessandro
AU - Garcia-Marcos, Luis
AU - Goh, Anne
AU - Gómez, René Maximiliano
AU - Gotua, Maia
AU - Hamelmann, Eckard
AU - Hedlin, Gunilla
AU - Hossny, Elham M.
AU - Ispayeva, Zhanat
AU - Jackson, Daniel J.
AU - Jartti, Tuomas
AU - Jeseňák, Miloš
AU - Kalayci, Omer
AU - Kaplan, Alan
AU - Konradsen, Jon R.
AU - Kuna, Piotr
AU - Lau, Susanne
AU - Le Souef, Peter
AU - Lemanske, Robert F.
AU - Levin, Michael
AU - Makela, Mika J.
AU - Mathioudakis, Alexander G.
AU - Mazulov, Oleksandr
AU - Price, David
AU - WAO Pediatric Asthma Committee
PY - 2024/4
Y1 - 2024/4
N2 - Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and patient well-being need to be monitored: response and adherence to treatment, disease control, disease progression, comorbidities, quality of life, medication side-effects, allergen and irritant exposures, diet and more. However, the prioritization of such factors and the selection of relevant assessment tools is an unmet need. Furthermore, rapidly developing technologies promise new opportunities for closer, or even “real-time,” monitoring between visits. Following an approach that included needs assessment, evidence appraisal, and Delphi consensus, the PeARL Think Tank, in collaboration with major international professional and patient organizations, has developed a set of 24 recommendations on pediatric asthma monitoring, to support healthcare professionals in decision-making and care pathway design. (Figure presented.).
AB - Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and patient well-being need to be monitored: response and adherence to treatment, disease control, disease progression, comorbidities, quality of life, medication side-effects, allergen and irritant exposures, diet and more. However, the prioritization of such factors and the selection of relevant assessment tools is an unmet need. Furthermore, rapidly developing technologies promise new opportunities for closer, or even “real-time,” monitoring between visits. Following an approach that included needs assessment, evidence appraisal, and Delphi consensus, the PeARL Think Tank, in collaboration with major international professional and patient organizations, has developed a set of 24 recommendations on pediatric asthma monitoring, to support healthcare professionals in decision-making and care pathway design. (Figure presented.).
KW - asthma management
KW - biomarkers
KW - childhood
KW - consensus
KW - diagnosis
KW - guidelines
KW - therapy
UR - http://www.scopus.com/inward/record.url?scp=85191179208&partnerID=8YFLogxK
U2 - 10.1111/pai.14129
DO - 10.1111/pai.14129
M3 - Article
C2 - 38664926
AN - SCOPUS:85191179208
SN - 0905-6157
VL - 35
JO - Pediatric Allergy and Immunology
JF - Pediatric Allergy and Immunology
IS - 4
M1 - e14129
ER -